Kamada - Asset Resilience Ratio

Latest as of June 2022: 0.00%

Kamada (KMDA) has an Asset Resilience Ratio of 0.00% as of June 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Kamada (KMDA) total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

ILA0.00

≈ $0.00 USD Cash + Short-term Investments

Total Assets

ILA304.13 Million

≈ $815.38K USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2009–2021)

This chart shows how Kamada's Asset Resilience Ratio has changed over time. See net assets of Kamada for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Kamada's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Kamada.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	ILA0.00	0%
Short-term Investments	ILA0.00	0%
Total Liquid Assets	ILA0.00	0.00%

Asset Resilience Insights

Limited Liquidity: Kamada maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company maintains a balanced mix of cash and short-term investments.

Kamada Industry Peers by Asset Resilience Ratio

Compare Kamada's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Regencell Bioscience Holdings Ltd NASDAQ:RGC	Drug Manufacturers - Specialty & Generic	43.05%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	3.73%
Yuhan Corp. KO:000100	Drug Manufacturers - Specialty & Generic	0.99%
Tonghua Dongbao Pharmaceutical Co Ltd SHG:600867	Drug Manufacturers - Specialty & Generic	1.96%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Guobang Pharma Ltd SHG:605507	Drug Manufacturers - Specialty & Generic	8.47%

Annual Asset Resilience Ratio for Kamada (2009–2021)

The table below shows the annual Asset Resilience Ratio data for Kamada.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2021-12-31	0.00%	ILA0.00 ≈ $0.00	ILA318.67 Million ≈ $854.34K	--
2020-12-31	18.55%	ILA39.07 Million ≈ $104.74K	ILA210.66 Million ≈ $564.79K	+0.57pp
2019-12-31	17.98%	ILA31.25 Million ≈ $83.77K	ILA173.80 Million ≈ $465.94K	-5.55pp
2018-12-31	23.53%	ILA32.50 Million ≈ $87.13K	ILA138.12 Million ≈ $370.28K	-1.31pp
2017-12-31	24.84%	ILA30.34 Million ≈ $81.34K	ILA122.11 Million ≈ $327.37K	+6.12pp
2016-12-31	18.72%	ILA18.66 Million ≈ $50.04K	ILA99.70 Million ≈ $267.28K	-4.08pp
2015-12-31	22.80%	ILA23.26 Million ≈ $62.36K	ILA101.99 Million ≈ $273.44K	-8.42pp
2014-12-31	31.22%	ILA37.35 Million ≈ $100.13K	ILA119.62 Million ≈ $320.69K	+20.41pp
2013-12-31	10.81%	ILA15.07 Million ≈ $40.39K	ILA139.38 Million ≈ $373.67K	-8.19pp
2012-12-31	19.00%	ILA16.93 Million ≈ $45.39K	ILA89.11 Million ≈ $238.91K	-0.74pp
2011-12-31	19.74%	ILA16.87 Million ≈ $45.22K	ILA85.45 Million ≈ $229.09K	-2.51pp
2010-12-31	22.25%	ILA20.36 Million ≈ $54.60K	ILA91.52 Million ≈ $245.37K	+21.41pp
2009-12-31	0.84%	ILA527.72K ≈ $1.41K	ILA62.91 Million ≈ $168.66K	--

pp = percentage points

About Kamada

TA:KMDA Israel Drug Manufacturers - Specialty & Generic

Market Cap

$371.30 Million

ILA138.49 Billion ILA

Market Cap Rank

#14043 Global

#161 in Israel

Share Price

ILA2401.00

Change (1 day)

-1.23%

52-Week Range

ILA2170.00 - ILA2870.00

All Time High

ILA3940.00